Related Experiment Video
Updated: Mar 18, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.4K
[An 87-year-old-man with late-onset frontotemporal dementia: a case-study]
Tijdschrift Voor Psychiatrie
|July 12, 2016
Summary
Diagnosing rare late-onset frontotemporal dementia (LO-FTD) in an elderly patient presented complex behavioral and memory symptoms. This case highlights the challenges in differentiating LO-FTD from other neurological and psychiatric conditions.
Area of Science:
- Neurology
- Geriatrics
- Neuropsychiatry
Background:
- Late-onset frontotemporal dementia (LO-FTD) is an uncommon neurodegenerative disorder.
- FTD diagnosis can be challenging due to overlapping symptoms with other conditions.
Observation:
- An 87-year-old male presented with behavioral disinhibition, nocturnal restlessness, and short-term memory deficits.
- Clinical presentation mimicked other psychiatric and neurological disorders.
Findings:
- Diagnostic process involved ruling out medication-induced mania, bipolar disorder, Alzheimer's disease, and atypical vascular dementia.
- CT scan results were crucial in excluding other dementia etiologies.
Implications:
- This case underscores the complexity of diagnosing LO-FTD.
- Highlights the importance of a thorough differential diagnosis in geriatric cognitive decline.
- Emphasizes the need for increased awareness and diagnostic tools for rare dementias.
Related Concept Videos
01:30Dementia
660
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
660
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K